Fas-Ligand involvement in end stage liver disease

s / Digestive and Liver Disease 47S (2015) e19–e42 e37 Conclusions NAFLD-HCC rises in the absence of cirrhosis in about 50% of the cases, and it is detected at a later tumor stage than in HCV-infected patients. Future research should identify patients with NAFLD who require surveillance in order to offer them the most timely and effective treatment. http://dx.doi.org/10.1016/j.dld.2015.01.081